Nanjing Drum Tower Hospital, affiliated with Nanjing University, released long-term follow-up results of a phase 2 trial using reprogrammed stem cells for severe heart failure. The hospital reported that 90% of patients showed significant recovery in heart function, with results published in Nature Medicine.
WHO:Nanjing Drum Tower Hospital (affiliated with Nanjing University)
WHAT:Released long-term follow-up results of a phase 2 clinical study of reprogrammed stem cells for severe heart failure, reporting significant heart function recovery in 90% of patients.
